Life Sciences in Focus: Emerging Technologies
LSX Investor Perception Survey 2019
In this extract from the LSX Investor Perception Survey 2019, survey respondents consider the potential of emerging technologies in the healthcare industry and the factors that would increase investment in companies utilising these technologies. The 3rd annual LSX Investor Perception Survey tracks sentiment, aims, and preferences among the life science investment community.
Download the white paper to:
LSX (formerly Biotech and Money) is an influential community of senior life science decision makers. Through our impactful events, powerful thought leadership content and unique networking opportunities, we exist to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare.